We are live on ! Find out more
SUPN icon

Supernus Pharmaceuticals
SUPN

235 hedge funds and large institutions have $1.59B invested in Supernus Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 90 increasing their positions, 67 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 28

34% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 67

10% more capital invested

Capital invested by funds: $1.45B → $1.59B (+$139M)

5% more funds holding

Funds holding: 223 → 235 (+12)

1.52% more ownership

Funds ownership: 102.33% → 103.85% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

28% less call options, than puts

Call options by funds: $2.84M | Put options by funds: $3.95M

Holders
235
Holders Change
+12
Holders Change %
+5.38%
% of All Funds
3.62%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
44
Increased
90
Reduced
67
Closed
28
Calls
$2.84M
Puts
$3.95M
Net Calls
-$1.11M
Net Calls Change
-$6.27M

Top Buyers

Rank Fund Capital Flow
1
PCH
Polar Capital Holdings
United Kingdom
+$19.1M
2
SIMG
Stephens Investment Management Group
Texas
+$10.3M
3
LCG
Lisanti Capital Growth
New York
+$9.24M
4
AC
Armistice Capital
New York
+$7.16M
5
GKIM
GW&K Investment Management
Massachusetts
+$6.4M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$12.4M
2
Millennium Management
Millennium Management
New York
-$9.89M
3
HP
HealthInvest Partners
Sweden
-$8.93M
4
Invesco
Invesco
Georgia
-$8.72M
5
Renaissance Technologies
Renaissance Technologies
New York
-$4.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMS
51
Pictet Asset Management (Switzerland)
Switzerland
$3.65M -$1.07M -35,239 -22%
MAM
52
Madison Asset Management
Wisconsin
$3.49M +$27.3K +899 +0.8%
Wells Fargo
53
Wells Fargo
California
$3.46M -$717K -23,641 -17%
Swiss National Bank
54
Swiss National Bank
Switzerland
$3.42M – – –
CWM
55
Congress Wealth Management
Massachusetts
$3.32M +$3.45M +113,846 New
BCC
56
Bridge City Capital
Oregon
$3.17M -$667 -22 -0%
Public Sector Pension Investment Board (PSP Investments)
57
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$3.16M – – –
Citadel Advisors
58
Citadel Advisors
Florida
$3.12M +$2.79M +91,880 +603%
PHP
59
Parkman Healthcare Partners
Connecticut
$3.05M +$130K +4,299 +4%
HSA
60
Hussman Strategic Advisors
Maryland
$3.03M +$334K +11,000 +12%
New York State Common Retirement Fund
61
New York State Common Retirement Fund
New York
$3.02M +$935K +30,822 +42%
UBS Group
62
UBS Group
Switzerland
$2.89M +$2.91M +95,951 +3,148%
State Board of Administration of Florida Retirement System
63
State Board of Administration of Florida Retirement System
Florida
$2.85M +$121K +3,997 +4%
American Century Companies
64
American Century Companies
Missouri
$2.73M -$1.27M -41,973 -31%
Millennium Management
65
Millennium Management
New York
$2.67M -$9.89M -325,862 -78%
New York State Teachers Retirement System (NYSTRS)
66
New York State Teachers Retirement System (NYSTRS)
New York
$2.64M +$6.07K +200 +0.2%
Tudor Investment Corp
67
Tudor Investment Corp
Connecticut
$2.51M +$531K +17,516 +26%
Prudential Financial
68
Prudential Financial
New Jersey
$2.51M -$2.83M -93,420 -52%
State of New Jersey Common Pension Fund D
69
State of New Jersey Common Pension Fund D
New Jersey
$2.45M -$847K -27,930 -25%
Janus Henderson Group
70
Janus Henderson Group
United Kingdom
$2.38M +$227K +7,494 +10%
SG Americas Securities
71
SG Americas Securities
New York
$2.37M +$879K +28,974 +56%
HF
72
HRT Financial
New York
$2.35M +$1.8M +59,202 +277%
ARC
73
Advisor Resource Council
Texas
$2.28M +$820K +27,037 +53%
Barclays
74
Barclays
United Kingdom
$2.26M +$458K +15,098 +24%
CSS
75
Cubist Systematic Strategies
Connecticut
$2.2M +$2.28M +75,303 New
1 2
3
4 5

SUPN Hedge Fund Activity: Q4 2021 in Review

235 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Supernus Pharmaceuticals (SUPN) for Q4 2021, worth a combined $1.59B — up 9.6% from $1.45B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new SUPN positions and 28 closed out — a net gain of 16 holders — while 90 added to existing stakes and 67 trimmed.

The largest buyer was Polar Capital Holdings, opening a new position worth an estimated $19.1M. The largest seller was BlackRock, cutting an estimated $12.4M.

  • 235 institutional investors held Supernus Pharmaceuticals (SUPN) as of Q4 2021, up from 223 in Q3 2021.
  • Funds reported $1.59B of Supernus Pharmaceuticals stock for Q4 2021, up 9.6% quarter-over-quarter.
  • 44 funds opened new Supernus Pharmaceuticals positions in Q4 2021 and 28 closed out, a net change of +16 holders.
  • The largest Supernus Pharmaceuticals buyer in Q4 2021 was Polar Capital Holdings, an estimated $19.1M added.
  • The largest Supernus Pharmaceuticals seller in Q4 2021 was BlackRock, an estimated $12.4M sold.

Based on aggregated 13F filings for Q4 2021.